Literature DB >> 22297643

Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.

Yoji Hirai1, Takenobu Yamamoto, Hiroshi Kimura, Yoshinori Ito, Kazuhide Tsuji, Tomoko Miyake, Shin Morizane, Daisuke Suzuki, Kazuyasu Fujii, Keiji Iwatsuki.   

Abstract

Hydroa vacciniforme (HV) is a rare photosensitivity disorder of childhood associated with Epstein-Barr virus (EBV)(+) T-cell infiltration. We have summarized clinical manifestations of HV, and analyzed EBV(+) T-cell subsets as well as EBV DNA load in lymphocyte fractions, in comparison with hypersensitivity to mosquito bites (HMB), an EBV-associated T/natural killer (NK) lymphoproliferative disorder. We found that 31 of 33 (93.9%) HV lesions were composed of EBV(+) T cells and reactive EBV(-) cytotoxic T cells, without significant CD56(+) cell infiltration, whereas many CD56(+) cells were present in 8 of 9 (88.9%) HMB lesions. Of 13 (20.6%) HMB patients with or without HV, 12 (92.3%) showed increased percentages (>32%) of NK cells in the peripheral blood, whereas in the 16 patients with HV alone, 14 (87.5%) showed no increase. Of the 11 HV patients, 10 (90.9%) had increased percentages (>5%) of circulating γδT cells, with a mean value of 15.7 ± 2.9%, and the γδT-cell fractions contained larger amounts of EBV DNA than non-γδT-cell fractions. A triple-labeling method revealed that all three HV patients examined had increased percentages of EBER(+), T-cell receptor (TCR)γδ(+), and TCRαβ(-) cells. Our observations indicate that HV is associated with increased numbers of EBV(+) γδT cells, whereas HMB is associated with EBV(+) NK cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22297643     DOI: 10.1038/jid.2011.461

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

Review 1.  How we treat chronic active Epstein-Barr virus infection.

Authors:  Akihisa Sawada; Masami Inoue; Keisei Kawa
Journal:  Int J Hematol       Date:  2017-02-16       Impact factor: 2.490

2.  Antiviral treatment of a boy with EBV-associated hydroa vacciniforme.

Authors:  Anja Pahlow Mose; Niels Fisker; Ole Clemmensen; Anette Bygum
Journal:  BMJ Case Rep       Date:  2014-11-24

3.  Clonal expansion of Epstein-Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions.

Authors:  Taizo Wada; Akiko Toga; Yasuhisa Sakakibara; Tomoko Toma; Minoru Hasegawa; Kazuhiko Takehara; Tomonari Shigemura; Kazunaga Agematsu; Akihiro Yachie
Journal:  Int J Hematol       Date:  2012-08-12       Impact factor: 2.490

4.  Recurrent scarring papulovesicular lesions on sun-exposed skin in a 22-year-old man.

Authors:  Melissa A Levoska; Jeffrey I Cohen; Irini Manoli; Chyi-Chia Richard Lee; Steven S T Ching; Jessica Shand; Deborah Tamura; Kenneth H Kraemer; John J DiGiovanna
Journal:  J Am Acad Dermatol       Date:  2017-09-28       Impact factor: 11.527

5.  Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites.

Authors:  Jeffrey I Cohen; Irini Manoli; Kennichi Dowdell; Tammy A Krogmann; Deborah Tamura; Pierce Radecki; Wei Bu; Siu-Ping Turk; Kelly Liepshutz; Ronald L Hornung; Hiva Fassihi; Robert P Sarkany; Lori L Bonnycastle; Peter S Chines; Amy J Swift; Timothy G Myers; Melissa A Levoska; John J DiGiovanna; Francis S Collins; Kenneth H Kraemer; Stefania Pittaluga; Elaine S Jaffe
Journal:  Blood       Date:  2019-05-07       Impact factor: 25.476

6.  Marked Increase of Circulating Double-Negative γδ T Cells in a Patient With Hydroa Vacciniforme-Like Lymphoma.

Authors:  Sang Yong Shin; Chang Hun Park; Duck Cho; Hee Jin Kim; Sun Hee Kim
Journal:  Ann Lab Med       Date:  2016-05       Impact factor: 3.464

Review 7.  EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.

Authors:  Stefan D Dojcinov; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Pathogens       Date:  2018-03-07

8.  Cytologic Analysis of Epstein-Barr Virus-Associated T/Natural Killer-Cell Lymphoproliferative Diseases.

Authors:  Akihiro Yachie
Journal:  Front Pediatr       Date:  2018-11-16       Impact factor: 3.418

9.  Hydroa Vacciniforme-Like Lymphoproliferative Disorder in Korea: Prognostic Implication of Clinical Signs and Whole Blood Epstein-Barr Virus DNA.

Authors:  Se Jin Oh; Jongeun Lee; Ji-Hye Park; Jong Hee Lee; Junhun Cho; Young-Hyeh Ko; Dongyoun Lee
Journal:  Ann Dermatol       Date:  2021-05-04       Impact factor: 1.444

Review 10.  Epstein-Barr virus-associated lymphoid malignancies: the expanding spectrum of hematopoietic neoplasms.

Authors:  Hiroshi Kimura; Jun-ichi Kawada; Yoshinori Ito
Journal:  Nagoya J Med Sci       Date:  2013-08       Impact factor: 1.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.